Loading...
PIM Kinase Inhibitor AZD1208 for Treatment of MYC-Driven Prostate Cancer
BACKGROUND: PIM1 kinase is coexpressed with c-MYC in human prostate cancers (PCs) and dramatically enhances c-MYC-induced tumorigenicity. Here we examine the effects of a novel oral PIM inhibitor, AZD1208, on prostate tumorigenesis and recurrence. METHODS: A mouse c-MYC/Pim1-transduced tissue recomb...
Na minha lista:
| Udgivet i: | J Natl Cancer Inst |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Oxford University Press
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4326311/ https://ncbi.nlm.nih.gov/pubmed/25505253 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/dju407 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|